NASDAQ:HURA | Free Cash Flow | TuHURA Biosciences, Inc./NV

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-09-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.41M$48,846.00-$4.46M
2025-12-31-$5.56M$27,850.00-$5.58M
2025-03-31-$4.74M$42,672.00-$4.78M
2024-12-31-$2.6M$21,408.00-$2.62M
2024-09-30-$1.89M
2024-06-30-$1.44M
2024-03-31-$3.83M
2023-09-30-$1.32M
2023-06-30-$1.51M
2022-09-30-$6.37M$859,000.00-$7.23M
2022-06-30-$4.99M
2021-09-30-$5.07M
2021-06-30-$4.69M
2020-09-30-$4.11M
2020-06-30-$2.58M
2019-09-30-$2.27M
2019-06-30-$1.81M
2018-09-30-$2.08M
2018-06-30-$2.53M
2017-09-30-$2.37M
2017-06-30-$3.45M
2016-09-30-$1.61M
2016-06-30-$1.55M
2015-09-30-$1.4M
2015-06-30-$808,594.00
2014-09-30-$971,516.00
2014-06-30-$973,339.00
2014-03-31-$884,503.00
2013-12-31-$1.03M
2013-09-30-$1.11M
2013-03-31-$2.12M
2012-12-31$53,253.00
2012-03-31-$147,244.00
2011-09-30$1,142.00
2010-09-30-$8,563.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$27.63M$76,083.00-$27.71M
2024-12-31-$14.73M$57,906.00-$14.79M
2024-06-30-$7.18M
2023-12-31-$11.95M$79,224.00-$12.03M
2023-06-30-$11.87M
2022-06-30-$20.39M
2021-06-30-$18.86M
2020-06-30-$7.93M
2019-06-30-$6.33M
2018-06-30-$9.85M
2017-06-30-$8.02M
2016-06-30-$5.15M
2015-06-30-$3.85M
2014-06-30-$4M
2013-12-31-$5.52M
2012-12-31-$578,035.00
2011-12-31-$228,689.00